On the day after the final dose, mice harboring each tumor subtype treated with solvent (untreated) or with palbociclib (treated) were sacrificed, and the tumors analyzed for the expression of KI67, a marker of proliferation (Figure 5A). The gene discussed is MKI67; the disease is neoplasm.